676 related articles for article (PubMed ID: 26716645)
21. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
Aiderus A; Black MA; Dunbier AK
BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
[TBL] [Abstract][Full Text] [Related]
22. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
23. Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis.
Pacilli A; Calienni M; Margarucci S; D'Apolito M; Petillo O; Rocchi L; Pasquinelli G; Nicolai R; Koverech A; Calvani M; Peluso G; Montanaro L
J Natl Cancer Inst; 2013 Apr; 105(7):489-98. PubMed ID: 23486551
[TBL] [Abstract][Full Text] [Related]
24. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.
Ezzeddini R; Taghikhani M; Salek Farrokhi A; Somi MH; Samadi N; Esfahani A; Rasaee MJ
J Physiol Biochem; 2021 May; 77(2):249-260. PubMed ID: 33730333
[TBL] [Abstract][Full Text] [Related]
26. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.
Zanella F; Renner O; García B; Callejas S; Dopazo A; Peregrina S; Carnero A; Link W
Oncogene; 2010 May; 29(20):2973-82. PubMed ID: 20208562
[TBL] [Abstract][Full Text] [Related]
27. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
Wang YN; Zeng ZL; Lu J; Wang Y; Liu ZX; He MM; Zhao Q; Wang ZX; Li T; Lu YX; Wu QN; Yu K; Wang F; Pu HY; Li B; Jia WH; Shi M; Xie D; Kang TB; Huang P; Ju HQ; Xu RH
Oncogene; 2018 Nov; 37(46):6025-6040. PubMed ID: 29995871
[TBL] [Abstract][Full Text] [Related]
28. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
[TBL] [Abstract][Full Text] [Related]
29. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis.
Su W; Hu Z; Zhong X; Cong A; Zhang Y; Zhou Z; Li J; Su C; Huang Y; Cao W
Theranostics; 2023; 13(13):4482-4496. PubMed ID: 37649600
[No Abstract] [Full Text] [Related]
30. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
Schlaepfer IR; Joshi M
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31900483
[TBL] [Abstract][Full Text] [Related]
31. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
32. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
33. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
[TBL] [Abstract][Full Text] [Related]
34. Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.
Sung GJ; Choi HK; Kwak S; Song JH; Ko H; Yoon HG; Kang HB; Choi KC
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):76-81. PubMed ID: 27793752
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of salusin-β is associated with poor prognosis in ovarian cancer.
Zhang Q; Chen WM; Zhang XX; Zhang HX; Wang HC; Zheng FY; Zhu FF
Oncol Rep; 2017 Mar; 37(3):1826-1832. PubMed ID: 28184918
[TBL] [Abstract][Full Text] [Related]
36. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
38. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
Wolf D; Wolf AM; Rumpold H; Fiegl H; Zeimet AG; Muller-Holzner E; Deibl M; Gastl G; Gunsilius E; Marth C
Clin Cancer Res; 2005 Dec; 11(23):8326-31. PubMed ID: 16322292
[TBL] [Abstract][Full Text] [Related]
39. Aspects of long-chain acyl-COA metabolism.
Tol VA
Mol Cell Biochem; 1975 Apr; 7(1):19-31. PubMed ID: 1134497
[TBL] [Abstract][Full Text] [Related]
40. Disturbance of Fatty Acid Metabolism Promoted Vascular Endothelial Cell Senescence via Acetyl-CoA-Induced Protein Acetylation Modification.
Lin T; Yang WQ; Luo WW; Zhang LL; Mai YQ; Li ZQ; Liu ST; Jiang LJ; Liu PQ; Li ZM
Oxid Med Cell Longev; 2022; 2022():1198607. PubMed ID: 35993026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
